Emory University's Woodruff Health Sciences: COVID-19 Vaccine Antibodies Weaker Vs. Delta/Kappa Viral Variants
July 15, 2021
July 15, 2021
ATLANTA, Georgia, July 15 (TNSJou) -- Emory University's Woodruff Health Sciences Center issued the following news release:
Antibodies induced by currently available mRNA vaccines can still neutralize the Delta and Kappa variants of the SARS-CoV-2 virus, but do so at a reduced potency, according to a report published in the New England Journal of Medicine.
The Delta variant, first identified in India and previously known as B.1.617.2, is now dominant in the United . . .
Antibodies induced by currently available mRNA vaccines can still neutralize the Delta and Kappa variants of the SARS-CoV-2 virus, but do so at a reduced potency, according to a report published in the New England Journal of Medicine.
The Delta variant, first identified in India and previously known as B.1.617.2, is now dominant in the United . . .